BI Trial No.1199-0378
Note: this clinical trial is currently closed to enrollment.
An Open-Label Study of the long-term safety and tolerability of nintedanib (by mouth), on top of standard of care, over at least 2 years, in children and adolescents with clinically significant fibrosing Interstitial Lung Disease (InPedILD®-ON)